Vaniqa News
Pharmaceutical manufacturing: news in brief - In-PharmaTechnologist.com
The portfolio acquired consists of two dermatology products: Solaraze (diclofenac sodium) and Vaniqa (eflornithine). The six other products include: Lodine ...
PRESS DIGEST - British business press =6 - Reuters
The drugs to be sold include the dermatological products Solasaze and Vaniqa and six other non-promoted drugs. The disposal will enable Shire to invest more ...
Shire To Sell Portfolio Of Non-core Products To Almirall For $213 ... - RTT News
The divested portfolio includes the dermatology products, solaraze and vaniqa, and six other non-promoted products1 across a range of indications. ...
Shire Announces Sale Of Non Core Products Portfolio To Almirall ... - RTT News
The non-core products portfolio includes the dermatology products SOLARAZE and VANIQA, and six other non-promoted products1, which are principally sold by ...
Shire sells non core products for $213m - ShareCast
Solaraze, a treatment for skin lesions on areas damaged by sunlight, is to go, as is Vaniqa, a cream used on female facial hair, and six other non-promoted ...
Shire sells portfolio of non-core products to Almirall for 213 mln ... - Hemscott
The portfolio includes the dermatology products Solaraze and Vaniqa, apart from six other non-promoted products across a range of indications, ...
Shire sells medicines to Almirall for $213 mln - Reuters.uk
Shire, Britain's third-biggest drugmaker, said the portfolio included skin treatments Solaraze and Vaniqa and that the medicines were not in its core ...
Shire sells medicine portfolio - BBC News
Shire said the products included skin treatments Solaraze and Vaniqa and that the medicines were not in its core therapeutic areas. ...
Shire Divests Non-Core Product Portfolio to Almirall - CNNMoney.com
VANIQA is a topical prescription medicine for treating unwanted facial hair in women. Shire's strategic goal is to become the leading specialty ...
Shire Announces Sale Of Non Core Products Portfolio To Almirall ... - RTT News
The non-core products portfolio includes the dermatology products SOLARAZE and VANIQA, and six other non-promoted products1, which are principally sold by ...
Vaniqa RSS Feed